Biomimetic Dendritic Cell-Based Nanovaccines for Reprogramming the Immune Microenvironment to Boost Tumor Immunotherapy.
Wang W, Zou C, Liu X, He L, Cao Z, Zhu M, Wu Y, Liu X, Ma J, Wang Y, Zhang Y, Zhang K, Wang S, Zhang W, Liu W, Lin W, Zhang Y, Guo Q, Li M, Gu J.
Wang W, et al. Among authors: zhang w, zhang k, zhang y.
ACS Nano. 2024 Dec 17;18(50):34063-34076. doi: 10.1021/acsnano.4c09653. Epub 2024 Dec 3.
ACS Nano. 2024.
PMID: 39625243